PRISM BioLab Co Ltd (206A) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	368.33M	132.92M	120.08M	116.68M
Cost of goods sold	109.57M	91.80M	80.20M	79.78M
Cost of revenue	109.57M	91.80M	80.20M	79.78M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	279.21M	325.83M	340.17M	281.70M
Operating expense	279.21M	325.83M	340.17M	281.70M
Total operating expenses	388.78M	417.63M	420.37M	361.48M
Operating income	-20.45M	-284.71M	-300.29M	-244.80M
Other non operating income	-2.65M	-304.00K	304.00K	-499.00K
EBT including unusual items	-29.28M	-284.94M	-317.06M	-241.85M
EBT excluding unusual items	-9.30M	-267.43M	-293.57M	-239.49M
Income tax expense	1.42M	605.00K	395.00K	815.00K
Effective tax rate	-	-0.21%	-0.12%	-
Other operating expenses	-	-	-	-
Net income	-30.70M	-285.55M	-317.45M	-242.67M
Net profit margin	-	-214.83%	-264.37%	-
Earnings per share	-	-	-	-
Interest and investment income	3.30M	3.07M	3.93M	4.16M
Interest expense	-	-	-	-
Net interest expenses	3.30M	3.07M	3.93M	4.16M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance